Cargando…

Commentary: Viral serology testing before cataract surgery: Where do we stand?

Detalles Bibliográficos
Autores principales:	Nayak, Bhagabat, Bhatt, Bhumija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023943/ https://www.ncbi.nlm.nih.gov/pubmed/35086205 http://dx.doi.org/10.4103/ijo.IJO_2484_21

Ejemplares similares

Commentary: Ocular biometry in a developing country’s perspective
por: Nayak, Bhagabat, et al.
Publicado: (2022)

Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)

Commentary: Deep learning in retinopathy of prematurity: Where do we stand?
por: Sen, Parveen, et al.
Publicado: (2022)

Commentary: Systemic versus imaging biomarkers for diabetic macular oedema – Where do we stand?
por: Rana, Vipin, et al.
Publicado: (2021)

Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Perioperative care in perforation peritonitis: Where do we stand?
por: Garg, Rakesh
Publicado: (2013)

Topical therapy of psoriasis: Where do we stand?
por: Thappa, DM, et al.
Publicado: (2017)

Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Surgical trials in India, where do we stand?
por: Khajanchi, M
Publicado: (2022)

Commentary: Functional outcome after successful laser for retinopathy of prematurity – Where we stand?
por: Rishi, Ekta, et al.
Publicado: (2019)

Hyperbaric oxygen therapy promotes neurogenesis: where do we stand?
por: Mu, Jun, et al.
Publicado: (2011)

Immunosenescence and Cytomegalovirus: where do we stand after a decade?
por: Pawelec, Graham, et al.
Publicado: (2010)

Platelet Rich Plasma in Androgenic Alopecia: Where do we Stand?
por: Godse, Kiran
Publicado: (2014)

Treatment of Diabetes in Bullous Pemphigoid Patients: Where Do We Stand?
por: Alexandre, Maria Inês, et al.
Publicado: (2023)

Sperm DNA fragmentation testing: where we stand in 2017
por: Tandon, Salil
Publicado: (2017)

Calcium and Vitamin D in the Regulation of Energy Balance: Where Do We Stand?
por: Soares, Mario J., et al.
Publicado: (2014)

Commentary: Post blunt trauma high intraocular pressure and other damages to the anterior segment and management
por: Nayak, Bhagabat
Publicado: (2021)

Commentary: Enhancement of cognitive and surgical skills of phacoemulsification in residency or fellowship program: A multiapproach training
por: Nayak, Bhagabat
Publicado: (2021)

Commentary: Conventional phacoemulsification is going to stay for a long time
por: Nayak, Bhagabat, et al.
Publicado: (2022)

Risk stratification tools in prostate cancer, where do we stand?
por: Clinckaert, Andries, et al.
Publicado: (2021)

Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
por: Miller, Kathy D
Publicado: (2004)

Neoadjuvant targeted therapy for advanced renal cell carcinoma: Where do we stand?
por: Grivas, Nikolaos K.
Publicado: (2019)

Where Do We Stand?
Publicado: (1891)

Commentary: Aspheric intraocular lens may be the future but not always a simple solution
por: Nayak, Bhagabat, et al.
Publicado: (2022)

Intrauterine exposures, pregnancy estrogens and breast cancer risk: where do we currently stand?
por: Lagiou, Pagona
Publicado: (2006)

Ophthalmic research and publication in India: Where do we stand?
por: Nayak, Barun Kumar
Publicado: (2010)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
por: Choi, Jonggi, et al.
Publicado: (2016)

Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
por: Lundstrom, Kenneth
Publicado: (2023)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

The HIV self-testing debate: where do we stand?
por: Gagnon, Marilou, et al.
Publicado: (2018)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

The hazards and risks of inhaled poorly soluble particles – where do we stand after 30 years of research?
por: Borm, Paul J. A., et al.
Publicado: (2019)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand?
por: Azfr Ali, Ruba Saleh, et al.
Publicado: (2021)

Commentary: COVID-19—How it has impacted ophthalmic care and where do we go from here?
por: Gupta, Vivek, et al.
Publicado: (2020)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5pesmjjm9breo783cgeoa61a1